Predicting the acute-phase response fever risk in bisphosphonate-naive osteoporotic patients receiving their first dose of zoledronate.

Ke Lu Qin Shi Ya-Qin Gong Jia-Wei Shao Jian-Liang Wang

Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2022)

This study developed and validated nomogram prediction models that can predict APR fever risk in BP-naive OP patients receiving their first infusion of ZOL.

Keyphrases

hiv infected
low dose
bone mineral density
lymph node metastasis